These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 6388184
1. Malaria chemoprophylaxis--which drug? Biddulph J. P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184 [No Abstract] [Full Text] [Related]
2. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1985 Apr 12; 34(14):185-90, 195. PubMed ID: 3156271 [No Abstract] [Full Text] [Related]
3. [Malaria chemoprophylaxis. Resistance problems]. Danis M, Gentilini M. Arch Fr Pediatr; 1985 Dec 12; 42 Suppl 2():971-5. PubMed ID: 3914247 [Abstract] [Full Text] [Related]
4. Practical therapeutics malaria chemoprophylaxis. Juma FD. East Afr Med J; 1984 Mar 12; 61(3):254-9. PubMed ID: 6383777 [No Abstract] [Full Text] [Related]
5. The chemoprophylaxis of malaria. Chiodini PL. J Antimicrob Chemother; 1987 Sep 12; 20(3):297-302. PubMed ID: 3316145 [No Abstract] [Full Text] [Related]
7. A case of fansidar-resistant Plasmodium falciparum from Tanzania. De Geus A, Meuwissen JH, van Rijn A. Trop Geogr Med; 1982 Sep 12; 34(3):261-3. PubMed ID: 6758245 [No Abstract] [Full Text] [Related]
12. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1986 Jan 17; 35(2):21-22, 27. PubMed ID: 3001495 [No Abstract] [Full Text] [Related]
13. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea. Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B. Am J Trop Med Hyg; 2007 Nov 17; 77(5):947-54. PubMed ID: 17984359 [Abstract] [Full Text] [Related]
14. Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1989 May 26; 38(20):363-4. PubMed ID: 2497333 [No Abstract] [Full Text] [Related]
15. [Malaria prevention. Risk of infection in relation to preventive measures]. Weinke T, Trautmann M, Mravak S. Dtsch Med Wochenschr; 1986 Jul 11; 111(28-29):1101-5. PubMed ID: 3525080 [Abstract] [Full Text] [Related]
17. Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria. Ogunfowokan O, Dankyau M, Madaki AJ, Thacher TD. Am J Trop Med Hyg; 2009 Feb 11; 80(2):199-201. PubMed ID: 19190213 [Abstract] [Full Text] [Related]
18. A comparative study of malaria prophylaxis in peninsular Malaysia using chloroquine and a combination of sulphadoxine and pyrimethamine. Ponnampalam JT. J Trop Med Hyg; 1978 Oct 11; 81(10):198-203. PubMed ID: 366165 [No Abstract] [Full Text] [Related]
19. Malaria chemoprophylaxis: an update. Biddulph J. P N G Med J; 1987 Mar 11; 30(1):53-6. PubMed ID: 3303731 [No Abstract] [Full Text] [Related]
20. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Sowunmi A, Fehintola FA, Adedeji AA, Gbotosho GO, Tambo E, Fateye BA, Happi TC, Oduola AM. Trop Med Int Health; 2005 Nov 11; 10(11):1161-70. PubMed ID: 16262741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]